Home > Products

Products

You can also try the following methods, and our professionals will serve you Customized Consultation
Cat. No. Product Name Field of Application Chemical Structure
DC3160 Montelukast Sodium Featured Montelukast belongs to a group of medications known as leukotriene receptor antagonists.
DC8931 Mosapride Mosapride is a gastroprokinetic agent that acts as a selective 5HT4 agonist.
DC12485 Mosedipimod Mosedipimod (EC-18, 1-palmitoyl-2-linoleoyl-3-acetylglycerol) is a synthetic monoacetyldiaglyceride that stimulates T cell production of IL-2, IL-4, IL-12, IFN-γ, and GM-CSF in vitro.
DC7200 Motesanib Diphosphate (AMG-706) Featured Motesanib (AMG-706) is a potent ATP-competitive inhibitor of VEGFR1/2/3 with IC50 of 2 nM/3 nM/6 nM, respectively; similar activity against Kit, ~10-fold more selective for VEGFR than PDGFR and Ret.
DC10284 Motesanib Featured Motesanib is a potent ATP-competitive inhibitor of VEGFR1/2/3 with IC50s of 2 nM/3 nM/6 nM, respectively, and has similar activity against Kit, and is appr 10-fold more selective for VEGFR than PDGFR and Ret.
DC8815 Motolimod (VTX-2337) Featured Motolimod (VTX-2337) is a novel TLR8 agonist that activates NK cells and augments ADCC.
DC4226 Moxifloxacin hydrochloride Featured Moxifloxacin(Avelox, Avalox) is a fourth generation synthetic fluoroquinolone antibacterial agent.
DCAPI1331 Moxonidine Moxonidine
DCAPI1572 Moxonidine hydrochloride Moxonidine hydrochloride
DC10326 Mozavaptan Mozavaptan (OPC31260) is a orally effective, nonpeptide vasopressin V2 receptor antagonist with an IC50 of 14 nM.
DC22554 MP-A08 MP-A08 is a first-in-class, highly selective, ATP competitive sphingosine kinase (SphK) inhibitor (Ki of 6.9/27 uM for SK2/SK1).
DC11856 MPC-0767 MPC-0767 (MPC0767, MPC3100 mesylate hydrate) is an L-alanine ester prodrug of MPC-3100, which is a potent, selective, orally bioavailable Hsp90 inhibitor with IC50 of 0.14 uM.
DC22290 Aranidipine (MPC1304) Featured MPC1304 is a Ca2+ channel antagonist with potent and long-lasting antihypertensive effects. IC50 & Target: Ca2+ Channel.
DC7202 MPC-3100 MPC-3100 is an orally bioavailable, synthetic, second-generation small-molecule inhibitor of heat shock protein 90 (Hsp90) with potential antineoplastic activity.
DC8339 MPEP hydrochloride Featured MPEP is a potent, highly selective non-competitive antagonist at the mGlu5a receptor subtype (IC50 = 36 nM) while having no agonist or antagonist activities at the mGlu1b receptor at concentrations up to 30 μM.
DC1015 MPEP Featured MPEP is a selective mGlu5 receptor antagonist with IC50 of 36 nM.
DC20464 mPGES1-IN-16 mPGES1-IN-16 is a potent and selective mPGES-1 inhibitor with IC50 of 1 nM.
DC20465 mPGES1-IN-17d mPGES1-IN-17d is a potent, selective mPGES-1 inhibitor with enzyme IC50 of 8 nM, A549 cell IC50 of 16.24 nM, human whole blood IC50 of 249.9 nM.
DC11241 MP-HJ-1b MP-HJ-1b is a novel potent inhibitor of microtubule and tumor cell growth, binds the colchicine pocket at the intra-dimer interface, depolymerizes microtubules and affects spindle formation.
DC10063 MPI-5a Featured MPI_5a is a potent selective inhibitor of HDAC6, and poorly blocks other HDAC enzymes.
DC7470 MPI-0479605 Featured MPI-0479605 is an ATP competitive and selective inhibitor of mitotic kinase Mps1 with IC50 of 1.8 nM, >40-fold selectivity over other kinases.
DC8119 Mps1-IN-2 Featured Mps1-IN-2 is a potent Mps1 kianse inhibitor with IC50 value of 145 nM.
DC23974 Mps1-IN-3 Featured Mps1-IN-3 is a selective and highly potent Mps1 kinase inhibitor with IC50 of 50 nM.
DC10951 MPT0E028 MPT0E028 is a potent HDAC inhibitor that inhibits nuclear HDAC activity with IC50 of 11.1 nM in HeLa cells, 9-30 times more potent than SAHA.
DC10938 MPT0G211 MPT0G211 is a novel potent, selective HDAC6 inhibitor with IC50 of 0.291 nM, displays >1,000-fold selectivity over other HDAC isoforms.
DC9542 MPTP (hydrochloride) Featured MPTP HCl induced reduction in the DOPAC HVA/dopamine (DA) ratio and increase in striatal ascorbate (AS) oxidation in rats
DC10437 MRE-269 Featured MRE-269 is an active metabolite of selexipag, and acts as a selective IP receptor agonist.
DC3122 MRK003 MRK003 is a γ-secretase inhibitor exhibits promising in vitro pre-clinical activity in multiple myeloma and non-Hodgkin's lymphoma.
DC23877 MRK-560 MRK-560 is a potent, brain-penetrant and orally bioavailable γ-secretase inhibitor that inhibits proteolytic cleavage of APP over the Notch pathway.
DC23655 MRK-623 MRK-623 is a potent, α2/α3 subunit functionally selectiviie GABAA receptor agonist..

Customized Consultation X

Your information is safe with us. * Required Fields.

Your name
Company
Email
Procuct Name
Cat. No.
Remark
Verification code
Please fill out the characters in the picture
X